Equillium
EQ • NASDAQ
Equillium is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Stephen Connelly, with a market cap of $90.1M.
CEOStephen Connelly
Market Cap$90.1M
Biotechnology
Healthcare
Employees44.0
Websiteequilliumbio.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Equillium
Date
Thursday, March 26, 2026 (in 2 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.18
Earnings History
Past 12 earnings reports for Equillium
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$0.06Est: -$0.19 | +68.4% | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.16Est: -$0.17 | +5.9% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.24Est: -$0.19 | -26.3% | - | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.16Est: -$0.26 | +38.5% | $4.4M | — | 10-K |
| Nov 13, 2024 | Q3 2024 | $0.00Est: -$0.26 | +100.0% | $12.2MEst: $15.4M | -21.0% | 10-Q |
| Aug 8, 2024 | Q2 2024 | $0.01Est: -$0.15 | +106.7% | $13.9MEst: $6.3M | +119.0% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.08Est: -$0.09 | +11.1% | $10.7MEst: $9.0M | +18.8% | 10-Q |
| Mar 25, 2024 | Q4 2023 | -$0.07Est: -$0.17 | +58.8% | $9.2MEst: $8.9M | +4.1% | 10-K |
| Nov 8, 2023 | Q3 2023 | -$0.11Est: -$0.21 | +47.6% | $8.9MEst: $8.0M | +10.9% | — |
| Aug 9, 2023 | Q2 2023 | -$0.10Est: -$0.21 | +52.4% | $9.1MEst: $8.0M | +14.1% | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.11Est: -$0.42 | +73.8% | $8.9MEst: $4.6M | +93.0% | 10-Q |
| Mar 23, 2023 | Q4 2022 | $0.08Est: $0.72 | -88.9% | $15.8MEst: $38.0M | -58.5% | — |